Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Other Non-Current Assets (2016 - 2025)

BioCorRx's Other Non-Current Assets history spans 15 years, with the latest figure at $41936.0 for Q3 2025.

  • For Q3 2025, Other Non-Current Assets fell 16.26% year-over-year to $41936.0; the TTM value through Sep 2025 reached $41936.0, down 16.26%, while the annual FY2024 figure was $49784.0, 11.82% up from the prior year.
  • Other Non-Current Assets for Q3 2025 was $41936.0 at BioCorRx, roughly flat from $41936.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $6.0 million in Q1 2025 and bottomed at $29700.0 in Q2 2022.
  • The 5-year median for Other Non-Current Assets is $50374.0 (2024), against an average of $535177.5.
  • The largest annual shift saw Other Non-Current Assets tumbled 95.78% in 2022 before it skyrocketed 11801.96% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $703158.0 in 2021, then tumbled by 85.39% to $102706.0 in 2022, then plummeted by 56.65% to $44520.0 in 2023, then rose by 11.82% to $49784.0 in 2024, then fell by 15.76% to $41936.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Other Non-Current Assets are $41936.0 (Q3 2025), $41936.0 (Q2 2025), and $6.0 million (Q1 2025).